News

September 22, 2017September 22, 2017

National MS Society Among Groups Promoting Sept. 22 as Falls Prevention Awareness Day

Today is Falls Prevention Awareness Day, an annual campaign that occurs every Sept. 22 to encourage multiple sclerosis patients and others prone to falls to give a little extra ... Read more

September 22, 2017September 22, 2017

Study Links MIF, D-DT Molecules to Progressive Multiple Sclerosis Development

Two molecules known to regulate cellular signaling contribute to the underlying mechanism of progressive multiple sclerosis, found a recent study conducted by investigators at Oregon Health & Science University ... Read more

September 21, 2017September 22, 2017

Disarm Therapeutics to Begin Developing Therapy that Prevents Axonal Degeneration

News

Disarm Therapeutics has completed the first round of financing to develop a compound that prevents axonal degeneration in patients with multiple sclerosis and other neurodegenerative conditions. The treatment approach is ... Read more

September 21, 2017September 22, 2017

IQuity Taking Orders for RNA-based Blood Test That Can Detect MS Early with 90% Accuracy

News

The life science tech company IQuity has begun taking orders from physicians for an RNA-based blood test that can provide reliable yes or no results for multiple sclerosis in ... Read more

September 20, 2017September 20, 2017

Winner of $4.9 Million Research Award Tests Online and Teleconference-based Methods to Reduce MS-related Fatigue

News

People with multiple sclerosis (MS) often face geographic barriers that end up limiting their treatment options. That has led a Case Western Reserve University researcher to test online- and teleconference-based methods ... Read more

September 20, 2017September 20, 2017

ImStem, UConn Obtain U.S. Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases

News

The U.S. Patent and Trademark Office has issued a patent for human embryonic stem cells derived mesenchymal stem cells, called hES-T-MSC or T-MSC, and for their method of production. This ... Read more

September 19, 2017September 19, 2017

TG Therapeutics Recruiting Patients for Two Phase 3 Trials of Relapsing MS Therapy TG-1101

News

TG Therapeutics is recruiting participants for two Phase 3 clinical trials that will evaluate the safety and effectiveness of TG-1101 (ublituximab) as a treatment for relapsing forms of multiple sclerosis. ULTIMATE ... Read more

September 18, 2017September 19, 2017

Finnish Study Links Low Levels of Vitamin D to Higher Risk of MS in Women

News

Women with low levels of vitamin D in their blood are more likely to develop multiple sclerosis later in life, finds a large-scale study on women in Finland. Several studies ... Read more

September 18, 2017September 19, 2017

Synthon Wins EU Patent Case Against Teva, Paving Way for Generic Copaxone for MS Patients

News

A European Patent Office decision has opened the door to Synthon providing cheaper generic versions of Teva Pharmaceutical’s Copaxone to people with relapsing multiple sclerosis. What looks like the final ... Read more

September 15, 2017September 18, 2017

Probiotics Consumption May Improve Certain Disease Parameters in MS Patients, Study Suggests

News

Probiotics may improve the health of people with multiple sclerosis (MS) by reducing disability and improving inflammatory and metabolic parameters, an Iranian study shows. Live microorganisms linked to health benefits, ... Read more

September 15, 2017September 18, 2017

Five Research Projects Totaling $38 Million to Compare Effectiveness of MS Treatment Strategies

News

The Patient-Centered Outcomes Research Institute has awarded $38 million in grants for five projects that compare the effectiveness of different multiple sclerosis treatment strategies. A key aim of the research ... Read more

September 14, 2017September 15, 2017

Ocrevus Less Expensive, More Efficient than Interferon, Analysis Reveals

News

Ocrevus is a less expensive treatment option for relapsing multiple sclerosis than Rebif in the long-run, according to a cost-effectiveness analysis published in the Journal of Medical Economics. In addition ... Read more

September 14, 2017September 14, 2017

Specific Gut Bacteria May Drive Progression of Multiple Sclerosis, Study Finds

News

Specific gut bacteria may drive the progression of multiple sclerosis, according to a study showing that two bacterial species made the disease worse in a mouse model of MS. ... Read more

September 13, 2017September 14, 2017

Cognitive Impairment Worse Among PPMS Than RRMS Patients, German Study Finds

News

Patients with primary progressive multiple sclerosis have more severe cognitive impairment than those with relapsing-remitting multiple sclerosis, according to a German study that analyzed published data on the topic. PPMS ... Read more

September 13, 2017September 14, 2017

GT Biopharma to Develop New PainBrake Tablet Formulation to Treat MS Neuropathic Pain

News

GT Biopharma has acquired licensing and development rights for PainBrake — Accu-Break Pharmaceuticals’ non-opioid pain medication to treat dysesthesia and pain caused by nerve damage in multiple sclerosis. Currently ... Read more

September 12, 2017September 13, 2017

Concussion in Adolescence May Increase Risk of MS Later, Swedish Study Suggests

News

Having a concussion when you’re 11 to 20 years old could increase your risk of developing multiple sclerosis later, a Swedish study suggests. The collaboration between Örebro University and Karolinska ... Read more

September 12, 2017September 13, 2017

Swedish Study Suggests Stem Cell Transplants as Possible Treatment for Aggressive RRMS

News

Autologous hematopoietic stem cell transplants for relapsing-remitting multiple sclerosis are superior to currently approved disease-modifying drugs, according to a Swedish study published in the Journal of Neurology, Neurosurgery & ... Read more

September 11, 2017September 12, 2017

MS Humorist Yvonne DeSousa, in GeneFo Webinar, Offers Tips on How Laughter Can Make You Feel Better

News

Laughter really is among the best medicines when it comes to multiple sclerosis, says Yvonne deSousa, an MS patient, humorist and author who plans to share her tips on ... Read more

September 11, 2017September 12, 2017

Structural Eye Neurodegeneration Common Among MS Patients with Optic Neuritis, Danish Study Finds

News

Structural changes of the eye retina are a common feature among multiple sclerosis patients with a clinical history of optic neuritis, a Danish study finds. Loss of the myelin protective ... Read more

September 8, 2017September 11, 2017

US Hispanics Sought for Study of the Roles That Genetics and Culture Play in Severity of MS

News

University of Southern California researchers are recruiting 400 Hispanics who have been diagnosed with multiple sclerosis in the past two years for a study about genetics’ and cultural perceptions’ ... Read more

September 8, 2017September 11, 2017

Two Australians Win Fellowship Aimed at Breaking Barriers Between Basic and Therapy-development Research

News

Two researchers at the University of Tasmania’s Menzies Institute for Medical Research have received an innovative multiple sclerosis research fellowship that was created to drive basic scientific research into ... Read more

September 7, 2017September 9, 2017

Merck Extension Study Confirms Mavenclad’s Long-term Benefits in Relapsing MS Patients

News

Three-fourths of relapsing multiple sclerosis patients who took two short courses of Mavenclad over two years remained relapse-free for four years, according to newly published data from the medication’s ... Read more

September 7, 2017September 9, 2017

#MSParis2017 – Gilenya Reduces Relapses in Children and Adolescents with MS, Novartis Trial Shows

News

Gilenya decreased relapses in children and adolescents with multiple sclerosis in the phase 3 PARADIGMS trial, according to the therapy’s developer, Novartis. The Swiss company will present the trial’s results ... Read more

September 6, 2017September 6, 2017

Older Women with MS Age Better Than Their Male Counterparts, Canadian Survey Finds

News

Older men with multiple sclerosis (MS) have more harmful lifestyles than older women with the disease, concludes the Canadian Survey of Health, Lifestyle and Aging with Multiple Sclerosis. Treatment for depression ... Read more

September 6, 2017September 7, 2017

Dignity, Quest to Jointly Produce ‘Timo Solution’ to Manage Urinary Incontinence

News

Dignity Medical Solutions and Quest Specialty Products will jointly market the “Timo Solution” – a novel technology to manage urinary incontinence, a condition that frequently affects patients with multiple ... Read more

September 5, 2017September 6, 2017

MS Society of Canada Creates ‘Wellness Toolbox’ to Help Patients Manage Their Disease

News

The Multiple Sclerosis Society of Canada — with input from both experts and patients — has developed a “wellness toolbox” with strategies to help multiple sclerosis (MS) patients cope ... Read more

September 5, 2017September 6, 2017

#MSParis2017 – TG Therapeutics to Discuss Ublituximab’s Effectiveness at ECTRIMS–ACTRIMS Meeting in Paris

News

TG Therapeutics will discuss ublituximab’s ability to deplete B-cells linked to multiple sclerosis and to reduce inflammatory brain lesions at the 7th Joint ECTRIMS–ACTRIMS Meeting in Paris next month. The ... Read more

September 1, 2017September 5, 2017

Infection by Epstein-Barr Virus Increases MS Risk for African-Americans and Latinos, Study Finds

News

Past infection with the Epstein-Barr virus has been reported to increase the risk for multiple sclerosis. Now, researchers have found a link between EBV and MS in three racial-ethnic ... Read more

September 1, 2017September 5, 2017

#MSParis2017 – MediciNova to Share Results of Ibudilast Trial in Progressive MS at October Summit

News

MediciNova will present data from its clinical trial of ibudilast in progressive multiple sclerosis at the upcoming 7th Joint ECTRIMS – ACTRIMS Meeting in Paris. ECTRIMS and ACTRIMS selected the ... Read more

August 31, 2017August 31, 2017

Tecfidera Shows Promise as Replacement MS Therapy for Tysabri, Study Shows

News

Tecfidera (dimethyl fumarate) can be a suitable replacement therapy when Tysabri (natalizumab) is discontinued, keeping low levels of disease activity in patient with relapsing-remitting multiple sclerosis (RRMS), according to a report ... Read more

August 31, 2017August 31, 2017

MS and a Type of Schizophrenia May Belong to the Same Class of Disorders, Review Concludes

News

Striking similarities between patients with multiple sclerosis and a type of schizophrenia suggest the disorders are related, according to a review of a number of studies. Dr. Boris M. Arneth ... Read more

August 30, 2017August 30, 2017

Retroviral RRMS Treatment GNbAC1 Fails Phase 2 Trial, But Research Continues, Say Sponsors

News

A Phase 2b trial assessing the experimental retroviral-targeting treatment GNbAC1 in patients with relapsing-remitting multiple sclerosis (RRMS) failed to meet its primary goal of reducing brain lesions and other signs ... Read more

August 29, 2017August 29, 2017

Pancreas Secretes Factor That Can Rejuvenate Damaged Neuron Coating, Mouse Study Reports

News

A substance that the pancreas secretes can promote the regeneration of the protective nerve-cell coating that is damaged in multiple sclerosis, a mouse study shows. The substance is fibroblast growth ... Read more

August 29, 2017August 30, 2017

Merck’s Mavenclad, an Oral Therapy for Relapsing MS, Approved in European Union

News

The European Commission has approved Merck KGaA’s Mavenclad (cladribine tablets) to treat highly active relapsing forms of multiple sclerosis (MS). The Aug. 25 decision in Brussels marks the first approval of a ... Read more

August 28, 2017August 28, 2017

Minnesota Mom with Multiple Sclerosis Plunges into Twin Cities MuckFest

News

Beth Kantor, 42, now knows what it really means to get down in the dirt. For the past four years, she’s volunteered as a first-aid assistant at the annual ... Read more

August 28, 2017August 29, 2017

RRMS Patients Needed for Phase 3 Trial to Assess Adverse GI Effects of ALKS 8700 Therapy vs. Tecfidera

News

Alkermes is funding a Phase 3 clinical trial evaluating the effects of its ALKS 8700 therapy on the gastrointestinal tracts of relapsing-remitting multiple sclerosis (RRMS) patients, compared to Tecfidera (dimethyl fumarate), according to a news ... Read more

August 25, 2017September 4, 2017

Omega-3 Fatty Acids May Reduce Inflammation by Changing Immune Cell Processes, Study Suggests

News

Omega-3 fatty acids might reduce inflammatory processes by boosting a mechanism that cleans out dysfunctional or unnecessary proteins in a certain type of immune cells, according to a study ... Read more

August 25, 2017September 4, 2017

Topas and Lily Are Partnering to Develop Therapies for Autoimmune Disorders

News

Topas Therapeutics and Eli Lilly and Company are teaming up to develop compounds that could be used to treat inflammatory and autoimmune diseases, such as multiple sclerosis and diabetes. The ... Read more

August 24, 2017August 25, 2017

Horseback Riding Plus Standard Care Can Help MS Patients Improve Balance, Other Symptoms

News

Therapeutic horseback riding, also known as hippotherapy, when combined with standard care regimens significantly reduces fatigue and spasticity in multiple sclerosis. It also improves balance and quality of life, ... Read more

August 24, 2017August 25, 2017

MS Patients Can Use Smartphone to Take Part in Novartis Study of Movement Performance and Symptoms

News

A multiple sclerosis study will collect information about patients’ movement performance and symptoms from their smartphones, Novartis has reported. The study is aimed at evaluating in real time the daily ... Read more